- Home
- SPAI vs ESLA Comparison
SPAI vs ESLA Comparison
Compare SPAI & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPAI
- ESLA
- Stock Information
- Founded
- SPAI 2021
- ESLA 2021
- Country
- SPAI United States
- ESLA United States
- Employees
- SPAI N/A
- ESLA N/A
- Industry
- SPAI Industrial Specialties
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SPAI Health Care
- ESLA Health Care
- Exchange
- SPAI Nasdaq
- ESLA Nasdaq
- Market Cap
- SPAI 38.5M
- ESLA 35.9M
- IPO Year
- SPAI 2024
- ESLA N/A
- Fundamental
- Price
- SPAI $6.63
- ESLA $1.08
- Analyst Decision
- SPAI Strong Buy
- ESLA Strong Buy
- Analyst Count
- SPAI 1
- ESLA 1
- Target Price
- SPAI $8.00
- ESLA $16.00
- AVG Volume (30 Days)
- SPAI 387.2K
- ESLA 16.3K
- Earning Date
- SPAI 08-14-2025
- ESLA 08-12-2025
- Dividend Yield
- SPAI N/A
- ESLA N/A
- EPS Growth
- SPAI N/A
- ESLA N/A
- EPS
- SPAI N/A
- ESLA N/A
- Revenue
- SPAI $1,496,091.00
- ESLA N/A
- Revenue This Year
- SPAI N/A
- ESLA N/A
- Revenue Next Year
- SPAI N/A
- ESLA N/A
- P/E Ratio
- SPAI N/A
- ESLA N/A
- Revenue Growth
- SPAI 7.49
- ESLA N/A
- 52 Week Low
- SPAI $1.47
- ESLA $0.63
- 52 Week High
- SPAI $7.39
- ESLA $1.78
- Technical
- Relative Strength Index (RSI)
- SPAI 65.80
- ESLA 70.23
- Support Level
- SPAI $5.80
- ESLA $0.90
- Resistance Level
- SPAI $6.93
- ESLA $1.08
- Average True Range (ATR)
- SPAI 0.79
- ESLA 0.06
- MACD
- SPAI 0.16
- ESLA 0.02
- Stochastic Oscillator
- SPAI 79.55
- ESLA 97.84
About SPAI Safe Pro Group Inc. Common Stock
Safe Pro Group Inc operates to acquire security and protection products. Its emphasis is on the development of a cloud-based ecosystem for analyzing drone imagery and data utilizing proprietary artificial intelligence (AI), machine learning, deep learning, and applied computer vision software for hyper-scalable processing, analysis, and reporting. The company operated in three reportable business segments which consisted of: the business of Safe-Pro USA, the business of Airborne Response, and the business of Safe Pro AI. Key revenue is generated from Airborne Response.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.